Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: progesterone

« Back to Dashboard

Summary for Generic Name: progesterone

Drug Master File Entries: see list47
Suppliers: see list8
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)

Pharmacology for Ingredient: progesterone

Drug ClassProgesterone

Clinical Trials for: progesterone

Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor
Status: Recruiting Condition: Preterm Labor

Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
Status: Not yet recruiting Condition: Infertility

Comparing IM vs. Vaginal Progesterone for Pre-term Birth
Status: Completed Condition: Infant, Premature; Premature Birth

Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
Status: Completed Condition: Infertility

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
Status: Completed Condition: Infertility

Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Status: Recruiting Condition: Focus of the Study is to Determine if Oral Progesterone Administration Attenuates Drug-induced QT Interval Lengthening in Women

Sexual Absorption of Vaginal Progesterone
Status: Completed Condition: Infertility; Pregnancy

Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone
Status: Recruiting Condition: Progesterone Supplementation

Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women
Status: Not yet recruiting Condition: Premature Birth

Compare the Difference of P4 Concentration in Serum and Endometrium After Vaginal and IM P Administration
Status: Completed Condition: Postmenopausal Endometrium

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
INJECTABLE;INJECTION075906Apr 25, 2001RXNo<disabled><disabled>
INSERT, EXTENDED RELEASE;INTRAUTERINE017553Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Abbvie Inc
CAPSULE;ORAL019781Oct 15, 1999DISCNNo<disabled><disabled>
Watson Labs
GEL;VAGINAL020701Jul 31, 1997RXNo5,543,150<disabled><disabled>
Sofgen Pharms
CAPSULE;ORAL200456Sep 28, 2012RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn